HealthEquity (NASDAQ:HQY) EVP Sells $11,404.80 in Stock

HealthEquity, Inc. (NASDAQ:HQY) EVP Sunil Rajasekar sold 108 shares of the business’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $105.60, for a total transaction of $11,404.80. Following the completion of the transaction, the executive vice president directly owned 53,297 shares of the company’s stock, valued at $5,628,163.20. This trade represents a 0.20% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Sunil Rajasekar also recently made the following trade(s):

• On Thursday, October 15th, Sunil Rajasekar bought 108 shares of HealthEquity stock. The shares were bought at an average price of $90.33 per share, with a total value of $9,755.64.

HealthEquity Stock Up 1.3%

HealthEquity stock opened at $97.88 on Thursday. The company has a quick ratio of 2.99, a current ratio of 2.99 and a debt-to-equity ratio of 0.47. The firm has a market cap of $8.10 billion, a P/E ratio of 35.34, a P/E/G ratio of 1.53 and a beta of 0.24. The business has a fifty day moving average of $95.47 and a two-hundred day moving average of $91.72. HealthEquity, Inc. has a twelve month low of $72.76 and a twelve month high of $107.62.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. The business had revenue of $350.73 million for the quarter, compared to the consensus estimate of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. HealthEquity’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. On average, analysts forecast that HealthEquity, Inc. will post 3.93 earnings per share for the current fiscal year.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently made changes to their positions in the business. Leonteq Securities AG boosted its position in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares in the last quarter. Axiom Investment Management LLC purchased a new position in HealthEquity during the 1st quarter worth $33,000. Silvant Capital Management LLC purchased a new position in HealthEquity during the 2nd quarter worth $35,000. Public Employees Retirement System of Ohio purchased a new position in HealthEquity during the 2nd quarter worth $39,000. Finally, Caitong International Asset Management Co. Ltd increased its position in HealthEquity by 2,476.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 421 shares in the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research note on Friday, August 28th. Barclays boosted their target price on shares of HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a report on Friday, September 18th. Raymond James Financial reissued a “strong-buy” rating on shares of HealthEquity in a research report on Thursday, September 3rd. BMO Capital Markets raised their price target on shares of HealthEquity from $105.00 to $125.00 and gave the company an “outperform” rating in a report on Wednesday. Finally, Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $113.53.

About HealthEquity

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.